At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34 enrolled
Drug / intervention
Optiflowdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Preoxygenation With High Flow Nasal Oxygenation Using Optiflow - Does Speech Have an Effect on The End Tidal Oxygen Achieved When Compared to Closed Mouth Nasal Breathing?
University Hospital Southampton NHS Foundation Trust·interventional·Posted Dec 6, 2018·Updated Oct 30, 2020
In Brief
A clinical study evaluating Optiflow for Unrecognized Condition. Completed, enrolled 34 participants across 1 site.
Detailed Summary
If a patient speaks during the process of preoxygenation with high-flow nasal oxygen via the Optiflow™ system, is the efficacy reduced as measured by end-tidal lung oxygen content?
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUnrecognized Condition
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
Primary CompletionNov 2018
First PostedDec 2018
TodayJul 2026
First PostedDec 6, 2018
Enrollment StartOct 18, 2018
Primary CompletionNov 16, 2018
TodayJul 2, 2026
Enrollment to primary: 28 daysPosted 7.6 years ago
Interventions
Optiflowdevice
45l.min oxygen